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Interferon-induced proteins with tetratricopeptide repeats (IFITs) are a family of proteins,
which are strongly induced downstream of type I interferon signaling.The molecular mech-
anism of IFIT anti-viral activity has been studied in some detail, including the recently
discovered direct binding of viral nucleic acid, the binding to viral and host proteins, and
the possible involvement in anti-viral immune signal propagation. The unique structures of
some members of the IFIT family have been solved to reveal an internal pocket for non-
sequence-specific, but conformation- and modification-specific, nucleic acid binding. This
review will focus on recent discoveries, which link IFITs to the anti-viral response, intrinsic
to the innate immune system.
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INTRODUCTION
The germline-encoded innate immune system initiates a fast and
targeted response upon recognition of an invading virus. Most
research on the innate immune system is focused on how the
host senses and detects pathogen-associated molecular patterns
(PAMPs), including viral nucleic acids. Foreign nucleic acid within
the cytosol is an extremely potent PAMP, and the detection elic-
its a strong innate immune response (1). The host proteins that
sense viral PAMPs, termed pattern recognition receptors (PRRs),
range in their specific targets enormously and are located in endo-
somes and the cell cytosol (2–4). Some important PRRs that
are specific to virus nucleic acid recognition include Toll-Like
Receptors (TLRs) TLR3, TLR7, TLR8, and TLR9 (4, 5). Absent in
Melanoma 2 (AIM2)-like receptors such as the AIM2 inflamma-
some and IFI16 (6–9), and RIG-I-like receptors including MDA5
(melanoma differentiation associated gene 5) and RIG-I (retinoic
acid inducible gene I) (10, 11). The detection of various viral
nucleic acid species by these receptors elicits signaling cascades that
include the production of anti-viral genes and pro-inflammatory
cytokines, including type I interferons (IFNs) (1). These responses
slow virus replication by setting in motion a systematic anti-viral
response.
Type I IFNs are comprised of IFNα and IFNβ; these are respon-
sible for an array of biological and immunological functions
[reviewed in Ref. (12)]. Type I IFN signaling is mediated via
the IFNα/β receptor (IFNAR), and downstream signaling results
in the upregulation of IFN-stimulated genes (ISGs) (12). Begin-
ning with the innate immune sensing of virus infection, ISGs
encode many important protective and anti-viral pathways. ISGs
are directly responsible for blocking virus infection and priming
pro-inflammatory and adaptive immune response systems (12).
While the ISG class is quite large and diverse, this review will
focus on a family of proteins that recently emerged as having a
wide range of anti-viral functions: interferon-induced proteins
with tetratricopeptide repeats (IFITs). The detection of virus
infection by receptors and downstream pathways is of funda-
mental importance for our understanding of innate immunity
processes regulating cellular homeostasis. Moreover, innate mech-
anism leading to inhibition of virus replication is particularly
worth being investigated as they can possibly be harnessed for
anti-viral therapy design.
THE IFIT PROTEIN FAMILY
The IFIT family includes four canonical human members (IFIT1,
IFIT2, IFIT3, and IFIT5) and three mouse members (IFIT1, IFIT2,
and IFIT3), which are induced upon simulation with IFN, virus
infection, or other PAMP recognition (13, 14). Another human
IFIT, IFIT1B, is thought to be expressed in a non-IFN dependent
manner due to lack of an interferon-stimulated response element
(ISRE), which typically are present in two to three copies within
the promoters of the other IFIT genes (15, 16). IFIT5 is a par-
alog of IFIT1, which is absent in the murine genome. Instead,
another closely related gene seems to be present in the mouse,
Ifit1c (17). Moreover, two additional genes, Ifit1b and Ifit3b, are
part of the mouse repertoire. IFIT homologs have been discovered
in many vertebrate species: birds, fishes, and amphibians (15, 18).
Their conserved role throughout evolution hints to their general
importance. Since fish commonly contain multiple copies of IFIT
genes that most resemble IFIT1/5, it is tempting to speculate that
these IFITs are part of an ancient immune defense mechanism in
vertebrates (19).
While IFITs generally are not expressed in cells at high basal lev-
els, the transcription of IFIT genes rapidly increases during virus
infection or IFNAR signaling (16). Low levels of IFIT5 expression,
however, have been detected in HEK cells, which further increase
several-fold upon IFN stimulation (13). The presence of the ISREs
within the IFIT promoter region explains their low baseline-
transcriptional levels and fast IFN-dependent induction (16).
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FIGURE 1 | (A)The structures of human IFIT5 in complex with oligoA and
human IFIT1 NTD in cartoon representation (PDB entries 4HOT and 4HOU).
The subdomains identified in IFIT5 are color coded, and RNA is in red.
(B) Cross-section of the complex of IFIT5 with oligoA, showing a narrow
pocket that binds four nucleotides. (C)The structure of human IFIT2 (PDB
entry 4G1T) colored according to the corresponding IFIT5 subdomains.
Indicated are helices 7–9 that are swapped with the other protomer. (D)The
Y156 of IFIT5 forms a hydrogen bond (dotted line) with the 2′-O of the first
ribose (IFIT5 in complex with oligoU, PDB entry 4HOS). Metal ions are
depicted as spheres (Red, Mg2+; Purple, Na2+).
However, the kinetics of the transcriptional levels of specific IFITs
can be cell line and tissue dependent (20, 21). Moreover, the tran-
scriptional profile in different cell types could imply that specific
IFITs have various functions during virus infections in the host.
IFIT STRUCTURE
All IFIT proteins consist of repeats of the eponymous tetra-
tricopeptide (TPR) motif, which typically contains 34 amino
acids with the consensus sequence [WLF]-X(2)-[LIM]-[GAS]-X
(2)-[YLF]-X(8)-[ASE]-X(3)-[FYL]-X(2)-[ASL]-X(4)-[PKE] that
adopts a basic helix-turn-helix fold. Adjacent TPR motifs usually
form a sheet of antiparallel helices that curves into a super-helix,
and this unique fold presents concave and convex curved surfaces
that allow for binding of diverse ligands. TPR domains are con-
served in all kingdoms of life and are generally believed to serve
as protein and peptide recognition domains; with the discovery of
RNA-binding IFITs, the known ligand spectrum of TPR motifs is
broadened to also include nucleic acids.
The recent crystallographic structures of IFIT5 and the
N-terminal half of IFIT1 (NTD) (22–24) reveal that the usual
TPR super-helix is interrupted by an upside-down flip of the
N-terminal subdomain, but nevertheless the remainder of the
protein forms a concave surface that binds the 5′ end of RNA
(Figure 1A). The narrow pocket can accommodate up to four
nucleotides of exclusively single-stranded RNA (Figure 1B), and
the C-terminal subdomain tightens slightly around the aperture
upon ligand binding. Most notably is the pocket that engages the
5′ triphosphate extension of the single-stranded RNA. Whereas,
IFIT5 is monomeric, the structure of IFIT2 reveals a dimer (25),
and IFIT1, IFIT2, and IFIT3 form homodimers in solution (13).
The dimerization of IFIT2 occurs through swapping of three
helices belonging to TPR motifs 3 and 4 (Figure 1C). IFIT2 might
have a preference for double-stranded RNA (25), but it is not clear
where the RNA-binding interface is located. With IFIT1 and IFIT5
targeting the 5′ end, and IFIT2 binding the body of the RNA,
the IFIT proteins have diversified in the features of the non-self
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RNA that they recognize, described below, but it remains to be
shown whether they complement each other and act in concert in
a synergistic manner.
IFIT ANTI-VIRAL FUNCTION
Since IFITs are swiftly induced following virus infection, it is
hypothesized that IFITs play a role in the anti-viral milieu of cells.
Over the past years, many investigations have alluded to the impor-
tant anti-viral mechanisms of each IFIT family member. Below, we
will discuss the most important findings.
5′-TRIPHOSPHORYLATED AND 2′-O-UNMETHYLATED CAPPED RNA
BINDING
In general, cellular cytoplasmic RNAs are single stranded and con-
tain a 5′-monophosphate or N -7-methylated guanosine cap linked
by a 5′-to-5′ triphosphate bridge to the first base: rRNAs/tRNAs
and mRNAs, respectively. In higher eukaryotes, mRNA is further
modified with a methylated 2′-O position of the first ribose (26,
27). These modifications and secondary additions assist in not
only translational control, but the lack thereof plays a role in the
detection of foreign nucleic acid. In contrast, viruses may form
long double-stranded RNA, and/or generate triphosphorylated
RNA (PPP-RNA) during their life cycle, which elicits a strong
anti-viral response (28, 29). Using a proteomics approach, with
PPP-RNA as bait, a mass spectrometry analysis revealed IFIT1
as a major binding partner in HEK cells (13); thereby reveal-
ing a role for IFIT1 in recognizing and potentially sequestering
viral PPP-RNA, preventing it from being translated by the host
machinery (Figure 2A). From the proteomic and subsequent bio-
chemical analysis, it appeared as if only IFIT1 would bind the
PPP-RNA directly while IFIT2 and IFIT3 bind IFIT1 in a multi-
protein complex required for anti-viral activity (13). Knocking
down IFIT1, IFIT2, and IFIT3 in HeLa cells with siRNA resulted
in an increase rate of infection by viruses known to display a
PPP-RNA nucleic acid species during their life cycle such as Rift
Valley fever virus (RVFV), vesicular stomatitis virus (VSV), and
influenza A. In contrast, growth of Encephalomyocarditis virus
(EMCV), which does not produce a PPP-RNA species, was unaf-
fected by the presence or absence of IFIT1 (13). Moreover, studies
with IFIT1−/− mouse fibroblasts and myeloid cells also resulted
in increased replication of VSV, with no changes detected in pro-
inflammatory cytokines (13). Also, other studies determined that
IFIT2 protects mice from VSV neuropathogenesis (30), and IFIT3
expression in human A549 cells is required for IFNα-dependent
anti-viral activity against VSV (31).
As described above, higher eukaryotes and many viral RNAs are
not only methylated at the N -7 position, but also the 2′-O of the
5′ guanosine cap. The lack of the latter cap, common for foreign
nucleic acids, elicits a strong anti-viral response (32). Viruses lack-
ing this 2′-O-methylation, such as a West Nile virus (WNV) that
lacks 2′-O-methyltransferase activity, were unable to infect wild
type cells, but could replicate in cells lacking IFIT1 expression
(33, 34). Again, using proteomics, IFIT1 was discovered to have a
much stronger affinity for 2′-O uncapped vs. capped RNA, which
explains the IFIT1 mediated control of 2′-O-methyltransferase
deficient WNV (17). The study found that IFIT1 bound 2′-O-
unmethlyated RNA, which resulted in an inhibition of translation,
and therefore decreased virus infection (Figure 2A). Human IFIT5
has also been described to bind PPP-RNA (outside of the IFIT1–
IFIT2–IFIT3 complex), and also to uncapped 2′-O-unmethylated
RNA (13, 17) (Figure 2A). IFIT1 binding of 2′-O-unmethylated
RNA was also supported by another study that described a role for
IFIT1 in controlling Japanese Encephalitis Virus (JEV) 2′-MTase
mutant by binding preferentially to capped 2′-O-unmethylated
viral mRNAs (35).
IFIT1 can possibly accommodate capped RNA due to the
larger size of the binding cavity. Mutagenesis of IFIT1 in the
residue, which in IFIT5 makes contact with the 2′-OH of the first
nucleotide (Figure 1D), followed by pulldowns on RNA, suggests
that IFIT1 should be highly sensitive to the methylation status
of this moiety (22), with methylated RNA being a poor ligand.
Additionally, IFIT5 seems less sensitive to the disruption of 2′-O
binding, which enforces the notion of its high specificity for 5′PPP-
RNA, since 2′-O-methylation usually occurs in conjunction with
capping; there is also little evidence of sequence specificity in bind-
ing, as demonstrated by the structures of IFIT5 in complex with
oligoU, oligoC, and oligoA (22). Furthermore, IFIT family mem-
bers have been shown to effect translation by binding to mRNA
with various 5′-modifications (36).
These studies nicely define a role for IFITs in the preferential
binding to mis- or un-modified RNA in the cytoplasm; using a
key evolutionarily conserved feature of transcriptional regulation
to decipher self- vs. non-self nucleic acid.
INHIBITION OF VIRAL PROTEIN TRANSLATION
Eukaryotic cap-dependent protein translation relies on an N -
7-methylguanoside cap at the 5′ end of mRNA, compared to
the 5′-PPP-modified viral RNA species described above (37).
Evidence has shown that IFIT family members can lessen host
cap-dependent protein translation by binding to subunits of the
eukaryotic initiation factor 3 (eIF3) translation complex (38)
(Figure 2B). The eIF3 protein complex is required for trans-
lation initiation in several ways, including: mRNA recruitment,
scanning mRNA for the start codon, and tRNA delivery to the
translation machinery (37). Human IFIT1 and IFIT2 may perhaps
block function of eIF3 tRNA delivery while human IFIT2 and
mouse IFIT1 and IFIT2 may block mRNA recruitment (38–40).
The decrease in mRNA translation can have detrimental effects on
the host, though this also yields host-dependent virus replication.
Viruses can also use internal ribosome entry sites (IRESs) dur-
ing their replication for cap-independent translation, which also
requires eIF3 (37). It was discovered that human IFIT1 can sup-
press this IRES-dependent viral RNA translation during Hepatitis
C virus (HCV) infection (41). These studies, for which the mol-
ecular mechanism remains to be conformed, would suggest that
IFIT family members may, on top of the indirect effects through
RNA engagement, also affect virus translation directly, by altering
translational processes itself.
DIRECT VIRAL PROTEIN BINDING
While it has become clear that IFIT mechanism of anti-viral
activity is directed through binding foreign nucleic acid, yeast-
two-hybrid studies have suggested that IFITs can bind other
viral proteins. IFIT1 binds to E1, a viral helicase from Human
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FIGURE 2 | IFITs, once upregulated due to IFN signaling, play various
roles in blocking virus and host protein translation. IFIT1 can bind to
the (A) 5′ of mis-modified RNA either which is 2′-O-unmethylated or has
5′PPP-RNA (features of foreign nucleic acid) vs. properly capped host
mRNA. IFIT1, along with a complex of IFIT2 and IFIT3, can block
translation of these nucleic acids. Multiple IFITs have been described to
bind to various subunits of host (B) eIF3, a key component of mRNA
translation. Though the target of eIF3 is properly processed mRNA,
including host mRNA, IFIT1 may block translation cell-wide during virus
infection. As well, IFIT1 can bind (C) a key virulence factor of HPV,
helicase E1, and sequester it into the cytoplasm, thereby preventing virus
replication.
papillomavirus (HPV), which is required for replication (42, 43).
IFIT1 binds E1 and sequesters it within the cytoplasm, preventing
it from aiding in viral replication within nucleus (Figure 2C). This
was supported using a HPV virus expressing an E1 helicase with
a deleted F399amino acid residue, which was required for IFIT1
binding; the resulting virus had no loss of replication (43).
IFIT ROLE IN ANTI-VIRAL SIGNAL PATHWAY TRANSDUCTION
As well as being described as effector proteins in anti-viral replica-
tion, IFITs may also control downstream signaling, though some
controversies exist. Pichlmair et al., who originally described the
role of IFIT1 in binding PPP-RNA, noticed no decrease in type 1
IFNs produced in mouse fibroblasts, macrophages, or dendritic
cells lacking IFIT1 (13). Later, IFIT1 was proposed as one of
many innate immune“bottlenecks”and that the knocking down of
IFIT1 resulted in decreased pro-inflammatory responses after LPS
treatment of cells (44). In determining IFIT-mediated immune
pathways, a role for IFIT3 to interact with TBK1 (TNFR-associated
factor family member-associated NF-κB activator-binding kinase
1), an important innate immune modulating kinase (45), was out-
lined. This interaction of IFIT3 with TBK1 bridges the kinase
with mitochondrial anti-viral signaling (MAVS) on mitochondria;
over-expression or knock down of IFIT3 resulted in the increase
or decrease of anti-viral gene expression, respectively.
In contrast, groups have also reported immune suppres-
sive function of IFITs. By over-expressing IFIT2 in mouse
macrophages, Berchtold et al. observed reduced LPS-induced
expression of multiple pro-inflammatory cytokines including TNF
and IL-6 (46). This was associated with reduced mRNA stability
of the cytokine transcripts in the presence of increased IFIT2, sug-
gesting post-transcriptional regulation of inflammatory responses
(46). This phenomenon, however, could be due to the natural
function of IFIT family members to bind RNA and therefore
an over-expression could cause intrinsic cellular issues, as well
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as cell growth defects (47). Furthermore, IFIT1 and IFIT2 were
proposed to interact with stimulator of IFN genes (STING) (48),
which recruits TBK1 (described above to bind IFIT3 by Liu et al.)
and propagates phosphorylation of the transcription factor IRF3
(IFN regulatory transcription factor 3), activation of NF-κB, and
IFN production together with MAVS (49, 50). However, in this
case, over-expression of IFIT1 in HEK cells resulted in a decrease
of IRF3 activation and IFNβpromoter activation in response to
Sendai virus. Here, IFIT1 was described to disrupt the interaction
of STING with MAVS or TBK1 (48). Given the conflicting results
in pathway propagation and downstream immunological effects,
more investigative work must be done on the individual IFITs,
both in vitro and in vivo, in order to draw conclusions. More-
over, the extensive characterization of protein complexes formed
by IFIT family members in various cell lines using affinity purifi-
cation and mass spectrometry has failed to confirm any of these
interactions.
CONCLUSION
The IFIT family of proteins has recently been described as major
players in anti-viral innate immunity, and their huge cellular
abundance within the cell after ISG induction underscores their
importance. Currently, the molecular mechanism for which high-
resolution structure evidence exists, clearly defines a mechanistic
role of IFITs by binding to foreign nucleic acid: interfering with
viral processes, which expose a foreign 5′ configurations of RNA,
such as protein translation. However, more work must be focused
on determining the fate of the bound RNA: Are IFITs traffick-
ing foreign nucleic acid for destruction, or is the natural turnover
of IFIT naturally ridding the cell of foreign material? Moreover,
greater detailed investigation of IFIT effect on host-translational
machinery could lead to understanding of IFIT function in absence
of virus infection. Following-up on these unanswered questions
will better allow us to harness the potential activity of IFITs for
anti-viral treatments by exploiting the direct effect of halting
transcription of foreign nucleic acid, independently of sequence.
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